Atrae, Inc. Logo

Atrae, Inc.

Develops People Tech solutions for HR, including big data job sites and organizational analytics.

6194 | T

Overview

Corporate Details

ISIN(s):
JP3121890002
LEI:
Country:
Japan
Address:
港区麻布十番1−10−10
Sector:
Mining and quarrying
Industry:
Mining of non-ferrous metal ores

Description

Atrae, Inc. is a technology company that defines its business domain as “People Tech,” with a mission to create services that expand human potential. The company develops and manages IT solutions primarily for the Human Resources sector. Its portfolio includes contingent fee-based job websites that leverage big data to connect talent with opportunities. A key product is Wevox, a platform designed to analyze organizational health and improve corporate value, which is also offered through a joint venture with SMBC Group. Atrae also operates in the "Sports Tech" segment, consistently aiming to build businesses that attract people worldwide.

Unlock This Filing & Millions More

You're one step away from the data you need. Create a free account to instantly view this filing and get access to powerful research tools.

Filings

You have of free filing views remaining. Upgrade for unlimited access.
Quick Filters:

Filters

Clear
Bulk Actions:
Date Filing Language Size Actions
2025-10-14 09:46
Transaction in Own Shares
自己株券買付状況報告書(法24条の6第1項に基づくもの)
Japanese 26.2 KB
2025-09-12 08:55
Transaction in Own Shares
自己株券買付状況報告書(法24条の6第1項に基づくもの)
Japanese 22.8 KB
2025-05-14 08:05
Interim Report
半期報告書-第22期(2024/10/01-2025/09/30)
Japanese 166.2 KB
2025-05-14 08:05
Report Publication Announcement
確認書
Japanese 8.0 KB
2025-04-14 09:06
Transaction in Own Shares
自己株券買付状況報告書(法24条の6第1項に基づくもの)
Japanese 23.8 KB
2025-03-13 08:50
Transaction in Own Shares
自己株券買付状況報告書(法24条の6第1項に基づくもの)
Japanese 22.7 KB
2025-02-03 08:20
Share Issue/Capital Change
訂正臨時報告書
Japanese 37.7 KB
2025-01-14 07:16
Regulatory News Service
臨時報告書
Japanese 39.6 KB
2025-01-14 07:14
Regulatory News Service
臨時報告書
Japanese 29.8 KB
2024-12-23 01:58
Post-Annual General Meeting Information
臨時報告書
Japanese 21.8 KB
2024-12-19 02:05
Regulatory News Service
確認書
Japanese 8.0 KB
2024-12-19 02:04
Regulatory News Service
内部統制報告書-第21期(2023/10/01-2024/09/30)
Japanese 21.6 KB
2024-12-19 02:03
Annual Report
有価証券報告書-第21期(2023/10/01-2024/09/30)
Japanese 985.6 KB
2024-11-14 08:08
Earnings Release
臨時報告書
Japanese 18.2 KB
2024-10-11 08:52
Transaction in Own Shares
自己株券買付状況報告書(法24条の6第1項に基づくもの)
Japanese 23.5 KB

Automate Your Workflow. Get a real-time feed of all Atrae, Inc. filings delivered via API.

Explore Data Feeds →

Market Data

Market Data Not Available

Financials & KPIs

No data available

Unlock Full Financials for Atrae, Inc.

This data is available as part of our premium data solutions. Contact our team for access.

Need More History? Access decades of standardized financials for Atrae, Inc. via our API.

Get Historical Data →

Insider Transactions

Date Insider Name Position Type Shares Value
No insider transactions recorded for this company.

Peer Companies

Company Country Ticker View
Clear Channel Outdoor Holdings, Inc. Logo
An OOH ad platform connecting brands to consumers via digital billboards and data analytics.
United States of America CCO
CODEXIS, INC. Logo
Engineering high-performance enzymes for pharma, diagnostics, and life science manufacturing.
United States of America CDXS
Cogent Biosciences, Inc. Logo
Developing precision small molecule therapies for cancers, autoimmune, and rare diseases.
United States of America COGT
COMPASS Pathways plc Logo
Developing psilocybin therapies for severe mental health challenges like TRD and PTSD.
United States of America CMPS
COMSCORE, INC. Logo
Cross-platform audience measurement and media analytics for advertisers, publishers, and agencies.
United States of America SCOR
COPRO-HOLDINGS. Co., Ltd. Logo
Dispatches technical personnel to Japan's construction & plant industries.
Japan 7059
Corbus Pharmaceuticals Holdings, Inc. Logo
Clinical-stage oncology company developing targeted therapies like ADCs for cancer and obesity.
United States of America CRBP
Corvus Pharmaceuticals, Inc. Logo
Develops novel, targeted therapies for immune diseases and cancer.
United States of America CRVS
Coya Therapeutics, Inc. Logo
Developing Treg-modulating therapies for neurodegenerative and autoimmune diseases.
United States of America COYA
A creator agency connecting professionals in creative, tech, medical, and legal sectors.
Japan 4763

Talk to a Data Expert

Have a question? We'll get back to you promptly.